Cardiovascular disease risk factors and progression of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 3, 2009, Pages 240-246

  Abellan Van Kan, Gabor ^a   Rolland, Yves ^a   Nourhashémi, Fati ^a   Coley, Nicola ^b   Andrieu, Sandrine ^b   Vellas, Bruno ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Alzheimer's disease, epidemiology; Cardiovascular disease risk factors, older people; Diabetes; Geriatrics; Hypercholesterolaemia; Hypertension

Indexed keywords

AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 60749087356     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000203365     Document Type: Article

References (27)

1. Forette F, Seux ML, Steassen JA, et al: The prevention of dementia with antihypertensive treatment. Arch Intern Med 2002;162:2046-2052.
2. in't Veld BA, Ruitenberg A, Hofman A, et al: Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001;22:407-412.
3. Skoog I, Lernfelt B, Landahl S, et al: A 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
4. Shobab LA, Hsiung GR, Feldman HH: Cholesterol in Alzheimer's disease. Lancet Neurol 2005;4:841-852.
5. Li G, Higdon R, Kukull WA: Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 2004;63:1624-1628.
6. Biessels GJ, Staekenborg S, Brunner E, et al: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74.
7. Nash DT, Fillit H: Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol 2006;97:1262-1265.
8. Regan C, Katona C, Walker Z, et al: Relationship of vascular risk to the progression of Alzheimer disease. Neurology 2006;67:1357-1362.
9. Bhargava D, Weiner MF, Hynan LS, et al: Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol 2006;19:78-82.
10. Mielke MM, Rosenberg PB, Tschanz J, et al: Vascular factors predict rate of progression in Alzheimer's disease. Neurology 2007;69:1850-1858.
11. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
12. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
13. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al: The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 2003;7:91-96.
14. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Katz S, Ford AB, Moskowitz RW, et al: The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
16. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
17. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
18. Vellas B, Villars H, Abellan G, et al: Overview of the MNA - its history and challenges. J Nutr Health Aging 2006;10:456-463.
19. Pineda Cuenca M, Custardoy Olavarrieta J, Ortin Arroniz JM, et al: Degree of understanding, treatment and control of hypertension, hypercholesterolemia and diabetes mellitus in the general adult population. Aten Primaria 2004;33:254-260.
20. Whalley JW, Finlay DD, McNeill G: A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006;5:87-96.
21. Stewart R, White LR, Xue QL, Launer LJ: Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2007;64:103-107.
22. Stewart R, Masaki K, Xue QL, et al: A 32-year prospective study of change in body weight and incident dementia. The Honolulu-Asia Aging Study. Arch Neurol 2005;62:55-60.
23. Coley N, Gardette V, Toulza O, et al: Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR Study. Neuroepidemiology 2008;31:69-79.
24. Vellas B, Gauthier S, Allain H, et al: Consensus statement on dementia of Alzheimer type in the severe stage. J Nutr Health Aging 2005;9:330-345.
25. Auer SR, Sclan SG, Yaffee RA, et al: The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia. J Am Geriatr Soc 1994;42:1266-1272.
26. Barbarotto R, Cerri M, Acerbi C, Molinari J, et al: Is SIB better than MMSE in discriminating the cognitive performance of severely impaired elderly patients? Arch Clin Neuropsychol 2000;15:21-29.
27. Honig LS, Kukull W, Mayeux R: Atherosclerosis and AD. Neurology 2005;64:494-500.